Stability of cytomegalovirus antibodies in plasma during prolonged storage of blood components
- 1 January 1995
- journal article
- Published by American Society for Microbiology in Clinical and Diagnostic Laboratory Immunology
- Vol. 2 (1) , 25-9
- https://doi.org/10.1128/cdli.2.1.25-29.1995
Abstract
Cytomegalovirus (CMV) antibody testing is currently limited by manufacturers' guidelines to specimens stored for 7 days or less. We examined the stability of CMV antibodies in plasma from platelets and whole-blood units during storage using a rapid, automated, recombinant protein-based immunoassay which qualitatively detects total antibody to human CMV. Testing of single-donor apheresis platelets was performed on baseline serum and platelet-free plasma and on platelet-free plasma 8 days later. Indeterminate, positive, and negative CMV antibody results were maintained over time for 97% (75 of 77) of the platelet specimens. For whole-blood units, initial testing of donor serum and plasma obtained from erythrocyte segments took place within 7 days of phlebotomy. Indeterminate, positive, and negative CMV antibody results were maintained on subsequent analyses performed on erythrocyte segments at 2, 4, 6, and 8 weeks for 100% of whole-blood specimens. An important potential benefit of CMV antibody testing of stored platelets and blood is the elimination of a costly, dedicated, CMV-negative inventory. The study suggests that CMV antibody testing can be conveniently and reliably performed on blood components over the entire storage period.Keywords
This publication has 15 references indexed in Scilit:
- Detection of cytomegalovirus antibody in platelet concentrates by fluorescence immunoassay and latex agglutinationTransfusion, 1991
- CYTOMEGALOVIRUS SEROLOGIC STATUS AND POSTOPERATIVE INFECTION CORRELATED WITH RISK OF DEVELOPING CHRONIC REJECTION AFTER PULMONARY TRANSPLANTATIONTransplantation, 1991
- The risk of cytomegalovirus infection in solid organ and bone marrow transplant recipients: transfusion of blood productsTransfusion, 1990
- Cytomegalovirus Infections After Allogeneic Bone Marrow TransplantationClinical Infectious Diseases, 1990
- Successful Strategy for Prevention of Cytomegalovirus Interstitial Pneumonia After Human Leukocyte Antigen-Identical Bone Marrow TransplantationClinical Infectious Diseases, 1990
- Detection of cytomegalovirus antibody in stored blood products using latex agglutinationTransfusion, 1988
- PREVENTION OF HLA IMMUNIZATION WITH LEUKOCYTE-POOR PACKED RED-CELLS AND PLATELET CONCENTRATES OBTAINED BY FILTRATION1988
- PREVENTION OF REFRACTORINESS AND HLA-ALLOIMMUNIZATION USING FILTERED BLOOD PRODUCTS1988
- Diseases Produced by CytomegalovirusesMedical Clinics of North America, 1978
- Rise of Cytomegalovirus Antibodies in an Infectious-mononucleosis-like Syndrome after TransfusionBMJ, 1966